These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2924289)

  • 1. Long-term carcinogenicity of cyclophosphamide in two mouse strains with different spontaneous leukemia incidence.
    Petru E; Berger MR; Schmähl D
    Cancer Lett; 1989 Mar; 44(3):221-6. PubMed ID: 2924289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of the leukemogenic activity of haloperidol in mice.
    Wunderlich V; Fey F; Sydow G
    Neoplasma; 1987; 34(4):389-96. PubMed ID: 3658046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic activity of ASTA Z 7557 (INN mafosfamide) in transplanted and autochthonous experimental rodent tumors.
    Zeller WJ; Berger MR; Matys R; Schuhmacher J
    Invest New Drugs; 1984; 2(2):175-80. PubMed ID: 6469512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukaemogenic action of phorbol in intact and thymectomized mice of different strains.
    Armuth V
    Br J Cancer; 1976 Nov; 34(5):516-22. PubMed ID: 793608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chromosome effect of cyclophosphamide in various strains of mice].
    Emerit I; Levy A; Feingold J
    Ann Genet; 1976 Sep; 19(3):203-6. PubMed ID: 1086630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.
    Sato H; Boyse EA; Aoki T; Iritani C; Old LJ
    J Exp Med; 1973 Sep; 138(3):593-606. PubMed ID: 4727915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose chemotherapy as a prelude to intensive treatment of spontaneous leukemia-lymphoma in AKR mice.
    Rose WC; Rimm AA; Saltzstein EC; Truitt RL; Bortin MM
    J Natl Cancer Inst; 1975 Jul; 55(1):219-21. PubMed ID: 1159816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouse.
    Alberts DS; Peng YM; Chen HS; Struck RF
    Br J Cancer; 1978 Aug; 38(2):316-24. PubMed ID: 698048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenetic mechanisms in immune polioencephalomyelitis: induction of disease in immunosuppressed mice.
    Duffey PS; Martinez D; Abrams GD; Murphy WH
    J Immunol; 1976 Feb; 116(2):475-81. PubMed ID: 1249421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sister chromatid exchange induction in mouse B- and T-lymphocytes exposed to cyclophosphamide in vitro and in vivo.
    Wilmer JL; Erexson GL; Kligerman AD
    Cancer Res; 1984 Mar; 44(3):880-4. PubMed ID: 6607109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice.
    Kishk EA; Mohammed Ali MH
    Arch Gynecol Obstet; 2013 May; 287(5):1023-9. PubMed ID: 23224696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diaplacental carcinogenic effects of 5-azacytidine in NMRI-mice.
    Schmahl W; Geber E; Lehmacher W
    Cancer Lett; 1985 May; 27(1):81-90. PubMed ID: 2408741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive immunotherapy for mouse leukemias with antisera of "directed" specificity: synergism with the action of cyclophosphamide.
    Reif AE; Li RW; Robinson CM
    Cancer Treat Rep; 1977 Nov; 61(8):1499-508. PubMed ID: 922753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in sister chromatid exchange (SCE)-induction in vivo by cyclophosphamide in murine strains.
    Dragani TA; Zunino A; Sozzi G
    Carcinogenesis; 1981; 2(3):219-22. PubMed ID: 7273306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice.
    Bortin MM; Rose WC; Truitt RL; Rimm AA; Saltzstein EC; Rodey GE
    J Natl Cancer Inst; 1975 Nov; 55(5):1227-9. PubMed ID: 1546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.